BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl4-induced liver cirrhosis by protecting the intestinal barrier in rats. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 7 Issue 1 Pages: 6927 Pub: 2017 Jul 31 Epub: 2017 Jul 31 Authors Shi D , Lv L , Fang D , Wu W , Hu C , Xu L , Chen Y , Guo J , Hu X , Li A , Guo F , Ye J , Li Y , Andayani D , Li L , |
|
|
Pediococcus pentosaceus MIANGUAN2 Alleviates Influenza Virus Infection by Modulating Gut Microbiota and Enhancing Short-Chain Fatty Acid Production. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 12 Pages: Pub: 2024 Jun 18 Epub: 2024 Jun 18 Authors Chen Y , Song L , Chen M , Huang Y , Wang Z , Ren Z , Xu J , |
|
|
Protective effect of Pediococcus pentosaceus Li05 on diarrhea-predominant irritable bowel syndrome in rats. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 7 Pages: 3692-3708 Pub: 2024 Apr 2 Epub: 2024 Apr 2 Authors Wu Y , Li S , Lv L , Jiang S , Xu L , Chen H , Li L , |
|
|
New strain of Pediococcus pentosaceus alleviates ethanol-induced liver injury by modulating the gut microbiota and short-chain fatty acid metabolism. ✅
Go to Publication ✅
World journal of gastroenterology (World J Gastroenterol ) Vol: 26 Issue 40 Pages: 6224-6240 Pub: 2020 Oct 28 Epub: Authors Jiang XW , Li YT , Ye JZ , Lv LX , Yang LY , Bian XY , Wu WR , Wu JJ , Shi D , Wang Q , Fang DQ , Wang KC , Wang QQ , Lu YM , Xie JJ , Li LJ , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
